Role of genetic polymorphisms in CCL5/CCR5 axis to predict efficacy of regorafenib in patients with refractory metastatic colorectal cancer.

被引：0
|
作者：
Suenaga, Mitsukuni
Schirripa, Marta
Cao, Shu
Zhang, Wu
Yang, Dongyun
Marmorino, Federica
Bergamo, Francesca
Antoniotti, Carlotta
Rossini, Daniele
Ning, Yan
Okazaki, Satoshi
Berger, Martin D.
Miyamoto, Yuji
Gopez, Roel
Hanna, Diana L.
Barzi, Afsaneh
Mashima, Tetsuo
Yamaguchi, Toshiharu
Loupakis, Fotios
Lenz, Heinz-Josef
机构：
[1] USC Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA USA
[2] USC Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA USA
[3] Univ Pisana, UO Oncol Med 2, Azienda Osped, Ist Toscano Tumori, Pisa, Italy
[4] IRCCS, Ist Oncol Veneto, Oncol Med 1, Padua, Italy
[5] Univ Pisana, Azienda Osped, UO Oncol Med 2, Pisa, Italy
[6] San Filippo Neri Hosp, Rome, Italy
[7] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo, Japan
[8] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan
[9] Ist Toscano Tumori, Pisa, Italy
[10] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
596
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
    Singh, Santosh Kumar
    Mishra, Manoj K.
    Eltoum, Isam-Eldin A.
    Bae, Sejong
    Lillard, James W., Jr.
    Singh, Rajesh
    SCIENTIFIC REPORTS, 2018, 8
  • [22] CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
    Santosh Kumar Singh
    Manoj K. Mishra
    Isam-Eldin A. Eltoum
    Sejong Bae
    James W. Lillard
    Rajesh Singh
    Scientific Reports, 8
  • [23] CCR5/CCL5 axis inhibition reverses cisplatinchemoresistance phenotye in gastric cancer cells
    Brebi, Priscilla
    Reyes, Maria Elena
    Ili, Carmen Gloria
    Mora, Yuselin
    Buchegger, Kurt
    Riquelme, Ismael
    Zanella, Louise
    Lobos-Gonzalez, Lorena
    Burdiles, Camila
    Mora-Iagos, Barbara
    CANCER RESEARCH, 2023, 83 (07)
  • [24] Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial
    Suenaga, Mitsukuni
    Stintzing, Sebastian
    Cao, Shu
    Zhang, Wu
    Yang, Dongyun
    Ning, Yan
    Okazaki, Satoshi
    Berger, Martin D.
    Miyamoto, Yuji
    Schirripa, Marta
    Soni, Shivani
    Barzi, Afsaneh
    Heinemann, Volker
    Lenz, Heinz-Josef
    EUROPEAN JOURNAL OF CANCER, 2019, 107 : 100 - 114
  • [25] Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma
    Singh, Santosh K.
    Mishra, Manoj K.
    Rivers, Brian M.
    Gordetsky, Jennifer B.
    Bae, Sejong
    Singh, Rajesh
    CANCERS, 2020, 12 (04)
  • [26] CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value
    Battaglin, Francesca
    Baca, Yasmine
    Millstein, Joshua
    Yang, Yan
    Xiu, Joanne
    Arai, Hiroyuki
    Wang, Jingyuan
    Ou, Fang-Shu
    Innocenti, Federico
    Mumenthaler, Shannon M.
    Jayachandran, Priya
    Kawanishi, Natsuko
    Lenz, Annika
    Soni, Shivani
    Algaze, Sandra
    Zhang, Wu
    Khoukaz, Taline
    Roussos Torres, Evanthia
    Seeber, Andreas
    Abraham, Jim P.
    Lou, Emil
    Philip, Philip A.
    Weinberg, Benjamin A.
    Shields, Anthony F.
    Goldberg, Richard M.
    Marshall, John L.
    Venook, Alan P.
    Korn, W. Michael
    Lenz, Heinz-Josef
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [27] Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer
    Suenaga, Mitsukuni
    Mashima, Tetsuo
    Kawata, Naomi
    Wakatsuki, Takeru
    Horiike, Yuki
    Matsusaka, Satoshi
    Dan, Shingo
    Shinozaki, Eiji
    Seimiya, Hiroyuki
    Mizunuma, Nobuyuki
    Yamaguchi, Kensei
    Yamaguchi, Toshiharu
    ONCOTARGET, 2016, 7 (23) : 34811 - 34823
  • [28] Expression of CCR5 and its ligand CCL5 in pancreatic cancer
    Singh, Santosh Kumar
    Banerjee, Saswati
    Lillard, James W., Jr.
    Singh, Rajesh
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [29] Relationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan
    Ting, Ke-Hsin
    Ueng, Kwo-Chang
    Chiang, Whei-Ling
    Chou, Ying-Erh
    Yang, Shun-Fa
    Wang, Po-Hui
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [30] CCR5/CCL5 gene expression in colorectal cancer (CRC): Comprehensive profiling and clinical value
    Battaglin, F.
    Baca, J.
    Xiu, J.
    Shields, A. F.
    Goldberg, R. M.
    Arai, H.
    Wang, J.
    Jayachandran, P.
    Kawanishi, N.
    Lenz, A.
    Soni, S.
    Seeber, A.
    Abraham, J.
    Lou, E.
    Philip, P. A.
    Weinberg, B. A.
    Zhang, W.
    Marshall, J. L.
    Korn, W. M.
    Lenz, H-J.
    ANNALS OF ONCOLOGY, 2021, 32 : S559 - S560
12345